Showing results (21-30 of 688) with videos related to
Sort By:
Pageof 69
Hematology/Oncology Clinics of North America|November 8, 2011
Chronic myelogenous leukemia: role of stem cell transplant in the imatinib eraNitin Jain, Koen van BesienBioorganic & Medicinal Chemistry Letters|December 24, 2018
Multiple weak intercalation as a strategy for the inhibition of polymerasesNitin Jain, Simon H FriedmanJournal of Immunology (Baltimore, Md. : 1950)|January 13, 2017
Ibrutinib Therapy Increases T Cell Repertoire Diversity in Patients with Chronic Lymphocytic LeukemiaQingsong Yin, Mariela Sivina, Harlan Robins, et al.Hematology/Oncology Clinics of North America|August 25, 2004
Current guidelines in defining therapeutic strategiesAlessandra Ferrajoli, Michael J KeatingCancer|November 30, 2022
A phase 1 study to evaluate the safety, pharmacology, and feasibility of continuous infusion nelarabine in patients with relapsed and/or refractory lymphoid malignanciesPrajwal C Boddu, Jayastu Senapati, Farhad Ravandi-Kashani, et al.International Journal of Cancer|July 20, 2017
Activation of the B-cell receptor successively activates NF-κB and STAT3 in chronic lymphocytic leukemia cellsUri Rozovski, David M Harris, Ping Li, et al.Blood Neoplasia|February 14, 2025
Ibrutinib and venetoclax in combination for chronic lymphocytic leukemia: synergy in practiceNatalia Timofeeva, Nitin Jain, Varsha GandhiClinical Advances in Hematology & Oncology : H&O|July 28, 2017
Philadelphia chromosome-like acute lymphoblastic leukemia: progress in a new cancer subtypeJulia Wells, Nitin Jain, Marina KonoplevaMayo Clinic Proceedings|May 6, 2018
Chronic Lymphocytic Leukemia: Diagnosis and TreatmentPaolo Strati, Nitin Jain, Susan O'BrienCurrent Drug Targets|June 18, 2013
Curcumin: a boon to colonic diseasesRashmi Sareen, Nitin Jain, Vinay PanditPageof 69